BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IAS-USA//NONSGML PDA Calendar Version 1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:5da09b16e7eb415445df8ba5ae664cd5
ORGANIZER:registration@iasusa.org
DTSTAMP:20261025T233701Z
LOCATION:
SUMMARY:(Part 4 of 4) More Than One Problem: Mental Illness as a Contributing Factor of Pain and Substance Use in People With HIV
DESCRIPTION:Overview\n\nAssessment of Needs\nMental illness encompasses a large array of syndromes from mood disorders to thought disorders to personality disorders\, which can directly impact pain and substance use. This talk will provide a general overview of the interrelated aspects of mental illness\, pain\, and substance use among people with HIV (PWH). Additionally\, this talk will provide concrete guidance on screening and how to address the results of that screening.  Importantly\, this talk will address how primary HIV practitioners can address some complex problems when referral to other mental health practitioners is not available.\n\n\nThis webinar is part 4 of the 4-part webinar series on pain and addiction:\n\n 	Part 1: Chronic Pain in People With HIV: An Evidence-Based\, Practical Approach by Dr Jessica Merlin\, MD\, PhD\, MBA (University of Pittsburgh)\n 	Part 2: Medical Cannabis in People With HIV: What’s the Evidence Dr Jessica Merlin\, MD\, PhD\, MBA (University of Pittsburgh)\n 	Part 3: Opioid Use and HIV/Hepatitis C Made Easy: A Practical Implementation of the Evidence by Dr R. Douglas Bruce\, MD\, MA\, MS (Yale School of Medicine)\n\n\nLearning Objectives\nUpon completion of this webinar\, learners will be able to:\n\n 	Describe the key mental health diagnoses in people with HIV and chronic pain and how mental health impacts pain perception\n 	Initiate appropriate screening for mental health disorders\n 	Implement the basic principles of treatment for people with mental health disorder\, HIV\, and chronic pain\n\nRegistration\nNote: The IAS–USA acknowledges the importance of delivering the same high-quality education and resources to our audiences despite the challenging times we are experiencing due to the COVID-19 pandemic. In response\, the implementation of a nominal fee to process the claim of CME and CE credits for webinars has been postponed.\nWho Should Attend\nThis advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.\n\nThis activity is also relevant for registered nurses\, PharmDs\, and other health professionals.\n\nIndividual registration is required\, even if you are viewing as a group\, in order to receive CME credit or a certificate of participation.\n\nRegistration closes on Monday\, November 30\, 2020\, 4:00 PM (PT).\n\nCertificates will be available after the completion of the evaluation and claim form.\n\nFor more information or questions\, please contact the registration department at registration@iasusa.org or 415-544-9400.\nConflicts of Interest\nIn the interest of maintaining the independence of its CME activities\, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME)\, the IAS–USA requires all persons with control of content (eg\, faculty\, IAS–USA Board members\, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.\n\nThe ACCME defines a commercial interest as “any entity producing\, marketing\, re-selling\, or distributing health care goods or services consumed by\, or used on\, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned\, or controlled by\, an ACCME-defined commercial interest.”\n\nPresenter\n\nDr Bruce has no relevant financial affiliations to disclose. (Updated 12/01/20)\n\nPlanner/Reviewer\n\nPlanner/Reviewer 1 has no relevant financial affiliations to disclose. (Updated 11/25/20)\nPlanner/Reviewer 2 has no relevant financial affiliations to disclose. (Updated 12/01/20)\n\n\n\n\nContinuing Education Credits\n\nCME Credits\nThe International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nThe IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\nABIM MOC Points\nSuccessful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.\nNursing Credits\nEducational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.25 hours of continuing nursing education.\n\nEducational Review Systems is also approved for nursing continuing education by the state of California\, the state of Florida and the District of Columbia.\nPharmacy Credits\nEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.25 contact hours (0.125 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event\, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.\n\nUAN # 0761-9999-20-347-L02-P\n\nThis program is approved for 1.25 hours of pharmacotherapy credit.\n\n\n\n\nGrant Support\n\n\nThis activity is part of the IAS–USA national educational effort that is funded\, in part\, by charitable contributions from commercial companies. Per IAS–USA policy\, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity\, including its content\, development\, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.\n\nPLATINUM SUPPORTERS\n\nGilead Sciences\, Inc\nMerck &amp\; Co\, Inc\nViiV Healthcare\n\nSILVER SUPPORTER\n\nJanssen Therapeutics\nFrequently Asked Questions\nView our list of FAQs about attending a webinar.\n\nFurther Questions?\nPlease contact the registration department at registration@iasusa.org or 415-544-9400.
STATUS:CONFIRMED
CATEGORIES:Webinars
URL;VALUE=URI:https://www.iasusa.org/events/webinar-2020-bruce-s4/
DTSTART:20201201T180000Z
DTEND:20201201T191500Z
END:VEVENT
END:VCALENDAR